KPC Pharmaceuticals Inc (600422) — Financial Flexibility Index
KPC Pharmaceuticals Inc (600422) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of CN¥145.61 Million (operating CF CN¥113.07 Million minus capex CN¥32.53 Million) represents 0% of total liabilities (CN¥4.83 Billion). Check KPC Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
KPC Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for KPC Pharmaceuticals Inc across 27 annual periods. For the full cash flow conversion analysis, see 600422 cash generation efficiency.
Annual Financial Flexibility Index for KPC Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for KPC Pharmaceuticals Inc. Explore KPC Pharmaceuticals Inc (600422) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥379.80 Million | CN¥289.24 Million | CN¥4.83 Billion | ▼ -48.1% |
| 2024 | 0.15x | CN¥887.50 Million | CN¥808.07 Million | CN¥5.87 Billion | ▼ -24.0% |
| 2023 | 0.20x | CN¥863.97 Million | CN¥754.33 Million | CN¥4.34 Billion | ▲ +140.1% |
| 2022 | 0.08x | CN¥355.64 Million | CN¥253.90 Million | CN¥4.29 Billion | ▼ -32.8% |
| 2021 | 0.12x | CN¥487.80 Million | CN¥251.63 Million | CN¥3.95 Billion | ▼ -23.6% |
| 2020 | 0.16x | CN¥568.67 Million | CN¥409.94 Million | CN¥3.52 Billion | ▼ -35.5% |
| 2019 | 0.25x | CN¥776.85 Million | CN¥429.50 Million | CN¥3.10 Billion | ▲ +29.5% |
| 2018 | 0.19x | CN¥569.33 Million | CN¥352.07 Million | CN¥2.94 Billion | ▼ -3.0% |
| 2017 | 0.20x | CN¥511.27 Million | CN¥242.53 Million | CN¥2.56 Billion | ▼ -30.6% |
| 2016 | 0.29x | CN¥514.61 Million | CN¥311.16 Million | CN¥1.79 Billion | ▼ -32.6% |
| 2015 | 0.43x | CN¥687.43 Million | CN¥476.62 Million | CN¥1.61 Billion | ▼ -31.0% |
| 2014 | 0.62x | CN¥602.11 Million | CN¥379.13 Million | CN¥974.40 Million | ▲ +36.8% |
| 2013 | 0.45x | CN¥454.62 Million | CN¥241.97 Million | CN¥1.01 Billion | ▲ +46.9% |
| 2012 | 0.31x | CN¥336.55 Million | CN¥213.33 Million | CN¥1.10 Billion | ▲ +19.6% |
| 2011 | 0.26x | CN¥183.09 Million | CN¥140.24 Million | CN¥712.37 Million | ▼ -1.2% |
| 2010 | 0.26x | CN¥154.98 Million | CN¥90.82 Million | CN¥595.84 Million | ▼ -10.7% |
| 2009 | 0.29x | CN¥147.39 Million | CN¥128.57 Million | CN¥505.79 Million | ▲ +35.4% |
| 2008 | 0.22x | CN¥104.68 Million | CN¥91.59 Million | CN¥486.48 Million | ▼ -18.6% |
| 2007 | 0.26x | CN¥146.72 Million | CN¥130.06 Million | CN¥554.98 Million | ▲ +59.4% |
| 2006 | 0.17x | CN¥90.28 Million | CN¥61.25 Million | CN¥544.44 Million | ▲ +193.6% |
| 2005 | -0.18x | CN¥-115.25 Million | CN¥-174.52 Million | CN¥650.31 Million | ▼ -323.4% |
| 2004 | 0.08x | CN¥35.60 Million | CN¥-2.78 Million | CN¥448.75 Million | ▼ -75.6% |
| 2003 | 0.33x | CN¥93.32 Million | CN¥61.23 Million | CN¥286.76 Million | ▼ -35.5% |
| 2002 | 0.50x | CN¥97.00 Million | CN¥17.38 Million | CN¥192.11 Million | ▲ +21.0% |
| 2001 | 0.42x | CN¥85.20 Million | CN¥67.07 Million | CN¥204.24 Million | ▲ +39.8% |
| 2000 | 0.30x | CN¥71.96 Million | CN¥47.76 Million | CN¥241.15 Million | ▲ +20.4% |
| 1999 | 0.25x | CN¥72.90 Million | CN¥60.24 Million | CN¥294.19 Million | — |